TITLE

Identifying the Money Pits in conducting clinical trials

PUB. DATE
August 2008
SOURCE
Clinical Trials Administrator;Aug2008, Vol. 6 Issue 8, p88
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
34690117

 

Related Articles

  • Sites and sponsors find common ground to accelerate study start-up.  // Clinical Trials Administrator;Aug2008, Vol. 6 Issue 8, p85 

    The article focuses on two trends in clinical research in the U.S.: contract negotiation and study start-up. According to Daniel Ulrey of Midwest Clinical Support Inc., retention rates were little better at 50% of those enrolled. He says a clinical site would need a retention rate of 65%. The...

  • How to start a clinical trial program. JESITUS, JOHN // Dermatology Times;Jul2015, Vol. 36 Issue 7, p40 

    The article discusses how pharmaceutical companies conduct clinical trials for its new drugs and devices. It states the need of a separate location and one full-time study coordinator. It notes the need of physicians and staff to be familiar and traveling to investigator meetings. It mentions...

  • Evidence-based Clinical Practice Guideline for the Use of Pit-and-Fissure Sealants.  // Pediatric Dentistry;2016 Reference Manual, Vol. 38 Issue 6, p263 

    Background: This article presents evidence-based clinical recommendations for the use of pit-and-fissure sealants on the occlusal surfaces of primary and permanent molars in children and adolescents. A guideline panel convened by the American Dental Association (ADA) Council on...

  • Industry money skews drug overviews. Giles, Jim // Nature;9/22/2005, Vol. 437 Issue 7058, p458 

    Reports on the emergence of evidence on the impact of money from the pharmaceutical industry on medical literature in Chicago, Illinois. Conduction of clinical trials in several areas of medicine; Presentation of a study of meta-analysis of hypertension medications; Role of meta-analysis in...

  • Corcept Raises Financing for Corlux Clinical Trials.  // Bioworld Week;3/24/2008, Vol. 16 Issue 12, p3 

    The article reports on the money raised by Corcept Therapeutics Inc. in a private equity financing to conduct a Phase III clinical trial of Corlux in the U.S. The said money will be used to conduct the clinical trial of Corlux, a cortisol receptor (GR-II) antagonist, for treating psychotic...

  • Six Biotech startups to watch. MESSINA, JUDITH // Crain's New York Business;8/4/2014, Vol. 30 Issue 31/32, p0014 

    The article reports that biotechnology company, Immunovent, has created a more accurate method to conduct allergy tests using a brush called Local Antibody Mucosal Brush Diagnostic to gather cells from inside the nose or cheek. Topics include the amount of money spent annually on allergy tests...

  • �Mom, I Need More Cash��. John; Yates, Chris // Campus Life;Dec2001 Special Issue, Vol. 60 Issue 5, p54 

    Focuses on the problem of college students in the United States in handling money. Citation of the clinical trials undergone by college students in order to earn dollars; Attitudes of the students toward financial chaos; Reflection of financial responsibility on the conduct of students.

  • Improving Participant Adherence in Clinical Research of Traditional Chinese Medicine. Wenke Zheng; Bai Chang; Jing Chen // Evidence-based Complementary & Alternative Medicine (eCAM);2014, Vol. 2014, p1 

    Ensuring good participant adherence in clinical trials plays an important role in that poor adherence may jeopardize the internal validity of the trial. Improving adherence in clinical trials on traditional Chinese medicine (TCM) has long been a concern for Chinese researchers who are conducting...

  • The Money Pit 7.30PM, DAVE [...]. RW // Daily Mail;10/24/2015, p60 

    The Money Pit 7.30PM, DAVE ****

  • More Questions About COX-2 Arthritis Drugs.  // Tufts University Health & Nutrition Letter;Jan2005, Vol. 22 Issue 11, p2 

    Reports on the clinical trials conducted to identify the role of arthritis medication COX-2 inhibitors in increasing the risk of heart attacks and strokes. Results of the clinical trial conducted by researcher Garret A. Fitzgerald on Bextra, a COX-2 painkiller from Pfizer; Position of Pfizer...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics